A carregar...

Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction

Immune checkpoint inhibitors have been widely incorporated for cancer treatment in a variety of solid and hematologic malignancies. Multiple clinical trials have demonstrated the efficacy of PD-1/PD-L1 and CTLA-4 axis inhibition in the metastatic and adjuvant settings. Due to the risks of autoimmune...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Transl Med
Main Authors: Florou, Vaia, Puri, Sonam, Garrido-Laguna, Ignacio, Wilky, Breelyn A.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8267318/
https://ncbi.nlm.nih.gov/pubmed/34277835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-5207
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!